Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Miyoshi, S. Moriyama, T. Kunitomo, S. Nawa (2009)
Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.The Journal of thoracic and cardiovascular surgery, 137 2
Linda Koo, John Ho (1990)
Worldwide epidemiological patterns of lung cancer in nonsmokers.International journal of epidemiology, 19 Suppl 1
T. Yano, N. Miura, T. Takenaka, A. Haro, H. Okazaki, T. Ohba, H. Kouso, T. Kometani, F. Shoji, Y. Maehara (2008)
Never‐smoking nonsmall cell lung cancer as a separate entityCancer, 113
Y. Ichinose, T. Yano, H. Asoh, H. Yokoyama, I. Yoshino, Y. Katsuda (1995)
Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage.The Journal of thoracic and cardiovascular surgery, 110 3
R. Rami-Porta, D. Ball, J. Crowley, D. Giroux, J. Jett, W. Travis, M. Tsuboi, E. Vallières, P. Goldstraw (2007)
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2
P. Goldstraw, J. Crowley, K. Chansky, D. Giroux, P. Groome, R. Rami-Porta, P. Postmus, V. Rusch, L. Sobin (2007)
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2
T. Goya, H. Asamura, H. Yoshimura, H. Kato, K. Shimokata, R. Tsuchiya, Y. Sohara, T. Miya, Etsuo Miyaoka (2005)
Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.Lung cancer, 50 2
C. Toh, F. Gao, W. Lim, S. Leong, K. Fong, S. Yap, A. Hsu, P. Eng, H. Koong, A. Thirugnanam, E. Tan (2006)
Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 15
N. Thatcher, A. Chang, P. Parikh, J. Pereira, T. Ciuleanu, J. Pawel, S. Thongprasert, E. Tan, K. Pemberton, V. Archer, K. Carroll (2005)
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)The Lancet, 366
C. Mountain (1997)
Revisions in the International System for Staging Lung Cancer.Chest, 111 6
N. Goldstein, A. Mani, G. Chmielewski, R. Welsh, S. Pursel (1999)
Prognostic factors in T1 NO MO adenocarcinomas and bronchioloalveolar carcinomas of the lung.American journal of clinical pathology, 112 3
A. Inoue, K. Kobayashi, K. Usui, M. Maemondo, S. Okinaga, I. Mikami, M. Ando, K. Yamazaki, Y. Saijo, A. Gemma, H. Miyazawa, Tomoaki Tanaka, K. Ikebuchi, T. Nukiwa, S. Morita, K. Hagiwara (2009)
First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 9
S. Couraud, G. Zalcman, B. Milleron, F. Morin, P. Souquet (2012)
Lung cancer in never smokers--a review.European journal of cancer, 48 9
Kenji Suzuki, K. Nagai, J. Yoshida, M. Nishimura, Kenro Takahashi, T. Yokose, Y. Nishiwaki (1999)
Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinomaCancer, 86
P. Macchiarini, G. Fontanini, M. Hardin, Hsu Chuanchieh, D. Bigini, S. Vignati, R. Pingitore, C. Angeletti (1993)
Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer.The Journal of thoracic and cardiovascular surgery, 106 1
L. Sobin, Thomas Aquinas (1987)
TNM Classification of Malignant Tumours
Rush (2007)
The IASLC Lung Cancer Staging Project: proposals for revision of the N descriptors in the forthcoming seventh edition of the TNM Classification for lung cancerJ Thorac Oncol, 2
G. Scagliotti, P. Parikh, J. Pawel, B. Biesma, J. Vansteenkiste, C. Manegold, P. Serwatowski, U. Gatzemeier, R. Digumarti, M. Zukin, J. Lee, A. Mellemgaard, Keunchil Park, S. Patil, J. Rolski, T. Goksel, F. Marinis, L. Simms, K. Sugarman, D. Gandara (2008)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 21
P. Postmus, E. Brambilla, K. Chansky, J. Crowley, P. Goldstraw, E. Patz, H. Yokomise (2007)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung CancerJournal of Thoracic Oncology, 2
E. Calvo, J. Baselga (2006)
Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 14
(2006)
bronchioloalveolar carcinoma : Improvement in survival after release of the 1999 WHO classification of lung tumors
International Staging Committee
Ch. Wittekind, M. Gospodarowicz, L. Sobin (2009)
TNM Classification of Malignant Tumours, 7th Edition
T. Pechet, Shamus Carr, J. Collins, H. Cohn, J. Farber (2004)
Arterial invasion predicts early mortality in stage I non-small cell lung cancer.The Annals of thoracic surgery, 78 5
T. Tsuchiya, S. Akamine, M. Muraoka, Ryotaro Kamohara, K. Tsuji, S. Urabe, S. Honda, N. Yamasaki (2007)
Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.Lung cancer, 56 3
ORIGINAL ARTICLE Verification of the Newly Proposed T Category (Seventh Edition of the Tumor, Node, and Metastasis Classification) from a Clinicopathological Viewpoint in Non-small Cell Lung Cancer—Special Reference to Tumor Size Tokujiro Yano, MD,* Yosuke Morodomi, MD,* Kensaku Ito, MD,* Tsukihisa Yoshida, MD,* Akira Haro, MD,* Fumihiro Shoji, MD,* Takaomi Koga, MD,† and Yoshihiko Maehara, MD* Key Words: Non-small cell lung cancer, TNM classification, Tu- Introduction: This study first verified the T classification, which is mor size, Intratumoral vessel invasion, Pleural invasion. the major point of the revision regarding the seventh Tumor, Node, (J Thorac Oncol. 2010;5: 45–48) and Metastasis classification, from a viewpoint of the clinicopatho- logical findings at the primary tumor site in non-small cell lung cancer. rimary lung cancer is one of the most common malignan- Methods: The medical records of 1393 patients with non-small cell Pcies in the world. It has been the leading cause of cancer lung cancer who underwent a complete resection at this hospital death in Japan since 1998 and is still increasing in both from 1974 to 2003 were thoroughly reviewed for pathologic findings prevalence and mortality. Despite recent progress in both and survival. radiotherapy and chemotherapy, a surgical resection remains
Journal of Thoracic Oncology – Wolters Kluwer Health
Published: Jan 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.